Edition:
United States

Champions Oncology Inc (CSBR.OQ)

CSBR.OQ on NASDAQ Stock Exchange Capital Market

3.98USD
15 Dec 2017
Change (% chg)

$-0.01 (-0.25%)
Prev Close
$3.99
Open
$4.00
Day's High
$4.22
Day's Low
$3.98
Volume
5,019
Avg. Vol
7,255
52-wk High
$4.75
52-wk Low
$2.22

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Oct 5.20 -0.010
Jul 5.03 -0.061
FY 2017 Apr '17 3.72 -0.196
Jan '17 3.57 -0.128
Oct 4.46 -0.046
Jul 3.67 -0.259
FY 2016 Apr '16 2.84 -0.297
Jan '16 2.55 -0.277
Oct 2.97 -0.293
Jul 2.82 -0.335
FY 2015 Apr '15 3.24 -0.509
Jan '15 1.83 -0.505
Oct 1.88 -0.600
Jul 1.91 -0.637
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

No consensus analysis data available.

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 196.13 36.03
P/E High - Last 5 Yrs. -- 279.92 45.26
P/E Low - Last 5 Yrs. -- 93.48 24.26
Beta -0.47 0.82 0.91
Price to Sales (TTM) 2.50 117.54 5.90
Price to Book (MRQ) 117.79 23.08 5.74
Price to Tangible Book (MRQ) -- 26.92 7.33
Price to Cash Flow (TTM) -- 106.51 24.72
% Owned Institutions 38.09 5.59 1.38

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.48
Dividend Yield - 5 Year Avg -- 0.26 2.05
Dividend 5 Year Growth Rate -- 2.02 5.23
Payout Ratio(TTM) -- 98.85 46.14

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 16.74 -4.33 6.77
Sales (TTM) vs TTM 1 Yr. Ago 29.63 30.49 5.56
Sales - 5 Yr. Growth Rate 16.60 33.28 10.25
EPS (MRQ) vs Qtr. 1 Yr. Ago 78.24 -148.85 7.88
EPS (TTM) vs TTM 1 Yr. Ago 54.91 -- --
EPS - 5 Yr. Growth Rate -- 44.44 10.92
Capital Spending - 5 Yr. Growth Rate 8.10 41.25 15.15

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.81 2.55
Current Ratio (MRQ) 0.61 5.63 3.57
LT Debt to Equity (MRQ) -- 16.33 13.26
Total Debt to Equity (MRQ) -- 18.85 19.22
Interest Coverage (TTM) -- -144.78 43.79

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 41.37 43.82 54.87
Gross Margin - 5 Yr. Avg. 36.84 55.59 52.44
EBITD Margin (TTM) -24.21 -- --
EBITD - 5 Yr. Avg -75.71 -215.54 15.70
Operating Margin (TTM) -25.56 -635.70 6.77
Operating Margin - 5 Yr. Avg. -77.43 -232.57 11.08
Pre-Tax Margin (TTM) -26.11 -605.50 7.60
Pre-Tax Margin - 5 Yr. Avg. -79.42 -232.71 11.49
Net Profit Margin (TTM) -26.26 -603.22 3.83
Net Profit Margin - 5 Yr. Avg. -79.90 -236.06 7.78
Effective Tax Rate (TTM) -- 15.54 24.27
Effective Tax Rate - 5 Yr. Avg. -- 19.17 24.06

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 22,216,302 857,902,259
Net Income/Employee (TTM) -- -2,116,531 100,310,105
Receivable Turnover (TTM) 7.84 26.19 6.13
Inventory Turnover (TTM) -- 2.65 3.55
Asset Turnover (TTM) 2.41 0.43 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -63.30 -9.39 11.35
Return on Assets - 5 Yr. Avg. -96.50 0.13 12.32
Return on Investment (TTM) -223.35 -11.69 14.48
Return on Investment - 5 Yr. Avg. -179.32 3.37 16.13
Return on Equity (TTM) -257.25 -36.44 16.06
Return on Equity - 5 Yr. Avg. -212.42 5.73 17.32
  1 Year 3 Year 5 Year
Sales % 37.82 10.09 16.60
EPS (TTM) % 46.37 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Champions Oncology Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 38.09%
# of Holders: 18
Total Shares Held: 4,184,038
3 Mo. Net Change: 4,315
# New Positions: 4
# Closed Positions: 2
# Increased Positions: 7
# Reduced Positions: 5
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.